Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Cells with active Wnt signaling are less likely to turn into cancer when exposed to a cancer-causing gene.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Endocrine therapies for cancer significantly increase the risk of hair loss.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Edible seeds from the Cucurbitaceae family like pumpkin and watermelon seeds are nutritious and may have health benefits, but eating too much can cause side effects.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Lrig1 could be a marker for advanced sebaceous carcinoma.

The study suggests that analyzing DNA can help treat hair loss, but more research is needed.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Environmental factors and chemicals might affect hormone balance and contribute to common hair loss.

Allopregnanolone changes gene expression in glioblastoma cells.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Estrogen therapy can reduce skin aging but has cancer risks.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.